|
|
|
|
LEADER |
01093caa a2200337 ir4500 |
001 |
NSK01000468252 |
003 |
HR-ZaNSK |
005 |
20100414103228.0 |
008 |
030116s2002 ci ||| ||eng |
015 |
|
|
|a HP02-0288
|2 HR
|
035 |
|
|
|9 (HR-ZaNSK)468994
|
035 |
|
|
|9 (HR-ZaNSK)430116156
|
035 |
|
|
|a (HR-ZaNSK)000468252
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|
080 |
|
|
|a 579.85:615.01
|
100 |
1 |
|
|a Vigl, Marion
|
245 |
1 |
4 |
|a The use of Botulinum toxin in clinical neurology /
|c Marion Vigl, Daniela Foeldy, Julia Neuhauser, Eduard Auff, Peter Schnider.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 77 jed
|
650 |
|
7 |
|a Botulin
|x Farmakološka svojstva
|2 nskps
|
650 |
|
7 |
|a Botulin
|x Primjena
|2 nskps
|
700 |
1 |
|
|a Foeldy, Daniela
|
700 |
1 |
|
|a Neuhauser, Julia
|
700 |
1 |
|
|a Auff, Eduard
|
700 |
1 |
|
|a Schnider, Peter
|
773 |
0 |
|
|t Periodicum biologorum
|x 0031-5362
|g 104 (2002), 1 ; str. 31-37
|w nsk.(HR-ZaNSK)000005174
|
932 |
|
|
|a da
|
981 |
|
|
|z B1/02
|
998 |
|
|
|a rado0301
|a sobp0301
|c vebo040705
|c bpkp050202
|
886 |
0 |
|
|2 unimarc
|b 00911naa2 2200265 450
|